American pharmaceutical giant Pfizer and German biotech firm BioNTech will pay Britain’s GSK and Germany’s CureVac $740 million plus royalties to settle US legal disputes over Covid-19 vaccines, ...
May 22 (Reuters) - U.S. drugmaker Pfizer (PFE.N), opens new tab on Wednesday launched a new multi-year program to reduce its expenses by about $1.5 billion by the end of 2027, adding on to a $4 ...
Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot’s success in 2020 until after that year’s election, the Wall Street Journal reported, citing ...
Derek Saul has covered markets for the Forbes news team since 2021. Pfizer stock’s struggles continued Wednesday, as shares of the healthcare titan dropped to their lowest level since before the Covid ...
The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company executive to investigate an allegation that clinical testing related to the ...
Kansas on Monday sued Pfizer, accusing the company of misleading the public about its COVID-19 vaccine by hiding risks while making false claims about its effectiveness. In a lawsuit filed in the ...
British drugmaker GSK told Manhattan prosecutors that a former employee told colleagues Pfizer held back positive results until after the 2020 election. But the former employee, who worked at both ...
In a move that might allow them to sell drugs directly to patients, some drugmakers are getting into the telehealth business. Some major pharmaceutical companies are getting into the telehealth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback